Literature DB >> 23859454

Colonic necrosis due to calcium polystyrene sulfonate (Kalimate) not suspended in sorbitol.

María Dolores Castillo-Cejas, Inés de-Torres-Ramírez, Carmen Alonso-Cotoner.   

Abstract

Cation-exchange resins are used in the management of hyperkalemia, particularly in patients with end-stage renal disease. These resins were associated with gastrointestinal tract lesions, especially sodium polystyrene sulfonate (Kayexalate) mixed with sorbitol. We present a case of colonic necrosis after the administration of calcium polystyrene sulfonate (Kalimate) not suspended in sorbitol.

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23859454     DOI： 10.4321/s1130-01082013000400010

Source DB:  PubMed          Journal:  Rev Esp Enferm Dig        ISSN： 1130-0108            Impact factor:   2.086


  7 in total

1.  Colonic Necrosis Induced by Calcium Polystyrene Sulfonate.

Authors:  Helena Ribeiro; Eduardo Pereira; António Banhudo
Journal:  GE Port J Gastroenterol       Date:  2017-10-07

2.  Hepatic portal venous gas due to polystyrene sulfonate-induced enteritis.

Authors:  Toshiyuki Kubo; Kentaro Yamashita; Yoshihiro Yokoyama; Daisuke Hirayama; Tomohiro Shirata; Kei Mitsuhashi; Kei Onodera; Eiichiro Yamamoto; Katsuhiko Nosho; Hiroo Yamano; Terufumi Kubo; Shintaro Sugita; Tadashi Hasegawa; Hiroshi Nakase
Journal:  Clin J Gastroenterol       Date:  2018-01-22

3.  A phase 2 study on the treatment of hyperkalemia in patients with chronic kidney disease suggests that the selective potassium trap, ZS-9, is safe and efficient.

Authors:  Stephen R Ash; Bhupinder Singh; Philip T Lavin; Fiona Stavros; Henrik S Rasmussen
Journal:  Kidney Int       Date:  2015-02-04       Impact factor: 10.612

4.  Maintenance of serum potassium with sodium zirconium cyclosilicate (ZS-9) in heart failure patients: results from a phase 3 randomized, double-blind, placebo-controlled trial.

Authors:  Stefan D Anker; Mikhail Kosiborod; Faiez Zannad; Ileana L Piña; Peter A McCullough; Gerasimos Filippatos; Peter van der Meer; Piotr Ponikowski; Henrik S Rasmussen; Philip T Lavin; Bhupinder Singh; Alex Yang; Prakash Deedwania
Journal:  Eur J Heart Fail       Date:  2015-06-16       Impact factor: 15.534

5.  Long-term efficacy of oral calcium polystyrene sulfonate for hyperkalemia in CKD patients.

Authors:  Mi-Yeon Yu; Jee Hyun Yeo; Joon-Sung Park; Chang Hwa Lee; Gheun-Ho Kim
Journal:  PLoS One       Date:  2017-03-22       Impact factor: 3.240

6.  Prescription patterns of sodium and calcium polystyrene sulfonate in patients with hyperkalemia and chronic kidney disease receiving RAAS inhibitors.

Authors:  Hongru Ren; Silvia J Leon; Reid Whitlock; Claudio Rigatto; Paul Komenda; Clara Bohm; David Collister; Navdeep Tangri
Journal:  Clin Kidney J       Date:  2022-03-21

7.  Resin-Induced Colonic Pseudotumor: Rare Complication from Chronic Use of Potassium Binders in a Hemodialysis Patient.

Authors:  Mary Bui; Shyan-Yih Chou; Pierre Faubert; Pablo Loarte; Ronny Cohen
Journal:  Case Rep Nephrol       Date:  2016-02-29
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.